Skip to content

NRXPW NRX PHARMACEUTICALS INC

Follow

*W EXP 05/24/202 (warrant or right)

9 managers (9 13F filers) reported a position in NRXPW shares at 2024-09-30, 122,121 shares in all. 2 filers opened a position and 0 filers sold out during the quarter.

Managers
9
13F filers
9
New
2
Added
1
Reduced
2
Sold out
0
Shares held by filers
122,121

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2024

Filers in the available 13F reports with a share position at 2024-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Virtu Financial LLCin group Virtu Financial LLC34,688$2K<0.01%-6,59513F-HRTimelineGroup
TRUIST FINANCIAL CORPin group TRUIST FINANCIAL CORP38,965$1.75K<0.01%013F-HRTimelineGroup
TWO SIGMA SECURITIES, LLC17,400$783<0.01%new13F-HRTimeline
WOLVERINE ASSET MANAGEMENT LLCin group WOLVERINE ASSET MANAGEMENT LLC15,392$692<0.01%+50013F-HRTimelineGroup
UBS Group AGin group UBS Group AG15,251$686<0.01%-8,23013F-HRTimelineGroup
Johnson Financial Group, Inc.in group Johnson Financial Group, Inc.315$15<0.01%new13F-HRTimelineGroup
BANK OF AMERICA CORP /DE/in group BANK OF AMERICA CORP /DE/95$4<0.01%013F-HRTimelineGroup
Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T…15$1<0.01%013F-HRTimelineGroup
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$00%013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.